XOMA Overview
Upcoming Projects (XOMA)
-
Don’t see a project related to the company you care about? Create your own!
Upcoming & Overdue Catalysts (XOMA)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (XOMA)
-
XOMA Announces Preclinical Data Evaluating PTH1R in Treatment of Hyperparathyroidism and Humoral Hypercalcemia of Malignancy
Ticker: XOMA
Occurred on: Apr 18, 2017 -
XOMA Prices $25M Direct Offering of Common and Preferred Stock
Ticker: XOMA
Occurred on: Feb 13, 2017 -
XOMA Receives Orphan Drug Designation in the European Union for XOMA 358 for Treatment of Congenital Hyperinsulinism
Ticker: XOMA
Occurred on: Jul 20, 2016 -
XOMA Initiates Phase 2 Proof-of-Concept Study of XOMA 213
Ticker: XOMA
Occurred on: Jun 28, 2016
Strategic Initiatives (XOMA)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
